Labcorp will expand specimen collection kit production at its plant in Belgium to cater for growing demand in Europe, the Middle East and Africa. The North Carolina-headquartered services firm ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the ...

SEONGNAM-SI, South Korea--(BUSINESS WIRE)--AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early ...

Cullinan Therapeutics, Inc. has announced the European Medicines Agency's approval of its Clinical Trial Application for CLN-978, a CD19-targeting bispecific T cell engager, aiming to initiate a Phase ...

Greenwich LifeSciences, Inc. announced progress in its Phase III clinical trial FLAMINGO-01, which is studying its immunotherapy GLSI-100 to prevent breast cancer recurrences. The European Medicines ...

Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction in risk of IgG4-RD ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, today announced that it has received formal ...

Join us at HIMSS26, the premier event that brings together healthcare professionals, technology partners, policymakers and thought leaders for four days of learning, collaboration and inspiration.

The main market opportunities lie in developing comprehensive training and support services for implementing and integrating clinical quality management systems (CQMS) that align with evolving ...

Critical Path Institute's (C-Path) Type 1 Diabetes Consortium (T1DC) today announced that the European Medicines Agency (EMA) has issued a positive qualification opinion for pancreatic islet ...

AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now ...